Trial Profile
Trial of New Oral Anticoagulants vs. Warfarin for Post Cardiac Surgery Atrial Fibrillation
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Oct 2023
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Warfarin
- Indications Stroke; Thromboembolism
- Focus Therapeutic Use
- Acronyms NEW-AF
- 22 Oct 2023 Status changed from recruiting to completed.
- 17 Jun 2023 Planned End Date changed from 1 May 2023 to 1 Dec 2023.
- 17 Jun 2023 Planned primary completion date changed from 1 Apr 2023 to 1 Aug 2023.